CII
SAGE

Capital International Inc’s Sage Therapeutics SAGE Stock Holding History

Capital International Inc’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,429
Closed -$1.3M – 307
2021
Q1 		$1.3M Sell
17,429
-669
-4% -$54.9K 0.01% 272
2020
Q4 		$1.57M Sell
18,098
-25,573
-59% -$1.88M 0.01% 252
2020
Q3 		$2.67M Buy
43,671
+22,494
+106% +$1.14M 0.03% 208
2020
Q2 		$881K Sell
21,177
-262,609
-93% -$9.53M 0.01% 233
2020
Q1 		$8.15M Buy
283,786
+15,053
+6% +$872K 0.14% 121
2019
Q4 		$19.4M Buy
268,733
+2,453
+0.9% +$302K 0.27% 104
2019
Q3 		$37.4M Buy
266,280
+249,273
+1,466% +$41.7M 0.56% 81
2019
Q2 		$3.11M Buy
+17,007
New +$2.9M 0.22% 100

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Capital International Inc's SAGE Position: Q2 2021 in Review

Capital International Inc sold out of Sage Therapeutics (SAGE) in Q2 2021, closing a stake of 17,429 shares — an estimated $1.3M sold.

Capital International Inc first reported a position in SAGE in Q2 2019 and held it in 8 quarters. The position peaked at $37.4M in Q3 2019. 257 funds tracked by Wall St. Rank hold SAGE as of Q2 2021.

  • Capital International Inc reported no remaining Sage Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Capital International Inc sold 17,429 Sage Therapeutics shares in Q2 2021, an estimated $1.3M.
  • Capital International Inc first reported a position in Sage Therapeutics in Q2 2019 and held it in 8 quarters.
  • Capital International Inc's Sage Therapeutics position peaked at $37.4M in Q3 2019.
  • 257 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2021.

Based on Capital International Inc's 13F filing for Q2 2021, filed 16 Aug 2021.